Ignite Creation Date:
2024-05-06 @ 9:11 AM
Last Modification Date:
2024-10-26 @ 12:11 PM
Study NCT ID:
NCT02924402
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-11
First Post:
2016-09-14
Brief Title:
Study to Evaluate Safety and Tolerability of XmAb13676 Plamotamab in Patients With CD20-expressing Hematologic Malignancies
Sponsor:
Organization:
Xencor Inc